Active Surveillance ’25: The Year in Review

Intro: 0:00 Dr. Christian Pavlovich: 4:12 Dr. Brian Helfand: 14:58 Dr. Timothy Showalter: 31:45 Dr. Jonathan Epstein: 44:10 Q&A: 55:16 Howard Wolinsky has been on Active Surveillance for low-risk prostate cancer for 14 years and is the editor/publisher of TheActiveSurveillor.com, the first Substack newsletter covering Active Surveillance (AS). AS is a safe and effective approach of close monitoring of lower-risk prostate cancers [Gleason 6/Grade Group 1 to favorable intermediate-risk (Gleason 3+4=7/Grade Group 2) prostate cancers to avoid radical surgery or radiation therapy, which carry life-changing risks. Wolinsky, who for nearly 30 years was medical writer/editor of the Chicago Sun-Times and is a two-time nominee for the Pulitzer Prize for exposes on the American Medical Association, hosted a webinar, Active Surveillance 2025: Year In Review on Jan. 4, 2025. The program covered such topics as Artificial Intelligence, diet, and MRI-invisible lesions. Speakers included: -Jonathan Epstein, MD, former chief pathologist at Johns Hopkins University School of Medicine, one of the world's leading pathologists. Epstein, now based in New York City. —Brian Helfand, MD, PhD, chief of urology at NorthShore University HealthSystem outside Chicago, an expert on the genetics of prostate cancer, —Christian Pavlovich, MD, head of the Active Surveillance program at Johns Hopkins, who spoke on diet, —Timothy Showalter, MD, MPH, medical director of Artera AI, which in 2024 introduced the first AI test for prostate cancer to guide men  on deciding whether to go Active Surveillance and avoid aggressive treatment. In addition to http://TheActiveSurveillor.com, Wolinsky just launched  Prostate Cores at https://prostateblogmonthly.substack...., which consists summaries of research on  prostate cancer, but also BPH, prostatitis, and cancer survivorship. For more information, go to http://TheActiveSurveillor.com and Prostate Cores at https://prostateblogmonthly.substack....